Skip to main content
. 2019 Apr;10(2):226–234. doi: 10.21037/jgo.2018.12.10

Figure 2.

Figure 2

Survival curve of 2-year overall survival (OS) in patients with colon cancer treated with oxaliplatin-containing adjuvant chemotherapy based on T stage. Patients with T2–3 and T4 stage had 2-year OS of 84.2% and 61.1% (HR =2.669; 95% CI, 1.087–6.557; P=0.032).